Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects.
Jung SunwooSang Chun JiJaeseong OhMu Seong BanJi Yeon NamBongtae KimGeun Seog SongKyung-Sang YuIn-Jin JangSeung Hwan LeePublished in: Alimentary pharmacology & therapeutics (2020)
Tegoprazan 50 mg showed stronger gastric acid suppression than revaorazan 200 mg. Both drugs were well tolerated.
Keyphrases